ASTH - Company ID 0001083446
Astrana Health, Inc. (ASTH) reported revenue of $3.18B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $3.18B | +56.4% |
| FY 2024 | $2.03B | +46.7% |
| FY 2023 | $1.39B | +21.2% |
| FY 2022 | $1.14B | +47.8% |
| FY 2021 | $773.91M | +12.6% |
| FY 2020 | $687.18M | +22.6% |
| FY 2019 | $560.62M | +7.8% |
| FY 2018 | $519.91M | +45.9% |
| FY 2017 |
Astrana Health, Inc. (ASTH) reported revenue of $3.18B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, Astrana Health, Inc.'s revenue grew from $5.11M to $3.18B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $356.36M |
| +520.5% |
| FY 2017 | $57.43M | +30.4% |
| FY 2016 | $44.05M | +33.5% |
| FY 2015 | $32.99M | +214.7% |
| FY 2014 | $10.48M | +34.8% |
| FY 2013 | $7.78M | +52.2% |
| FY 2012 | $5.11M | - |